These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
741 related items for PubMed ID: 16100190
21. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial. Postma DF, Spitoni C, van Werkhoven CH, van Elden LJR, Oosterheert JJ, Bonten MJM. BMC Infect Dis; 2019 Jan 07; 19(1):17. PubMed ID: 30612559 [Abstract] [Full Text] [Related]
24. Respiratory fluoroquinolone monotherapy vs. β-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials. Choi SH, Cesar A, Snow TAC, Saleem N, Arulkumaran N, Singer M. Int J Antimicrob Agents; 2023 Sep 07; 62(3):106905. PubMed ID: 37385561 [Abstract] [Full Text] [Related]
27. The science of selecting antimicrobials for community-acquired pneumonia (CAP). File TM. J Manag Care Pharm; 2009 Mar 07; 15(2 Suppl):S5-11. PubMed ID: 19236135 [Abstract] [Full Text] [Related]
28. Antibiotic treatment outcomes in community-acquired pneumonia. Çilli A, Sayıner A, Çelenk B, Şakar Coşkun A, Kılınç O, Hazar A, Aktaş Samur A, Taşbakan S, Waterer GW, Havlucu Y, Kılıç Ö, Tokgöz F, Bilge U. Turk J Med Sci; 2018 Aug 16; 48(4):730-736. PubMed ID: 30119147 [Abstract] [Full Text] [Related]
34. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. Crit Care; 2005 Dec 06; 10(1):R8. PubMed ID: 16420641 [Abstract] [Full Text] [Related]